TP53 and pancreatic neoplasm: Recently, we demonstrated that p53-armed OBP-702 induces stronger ICD with secretion of ATP than non-armed OBP-301 against human and murine pancreatic cancer cells by activating p53 expression, apoptosis, and autophagy.29